These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21283514)

  • 1. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza.
    Dimitrov NB; Goll S; Hupert N; Pourbohloul B; Meyers LA
    PLoS One; 2011 Jan; 6(1):e16094. PubMed ID: 21283514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing tactics for use of the U.S. Antiviral Strategic National Stockpile for Pandemic (H1N1) Influenza, 2009.
    Dimitrov N; Goll S; Hupert N; Pourbohloul B; Meyers LA
    PLoS Curr; 2009 Nov; 1():RRN1127. PubMed ID: 20029665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic.
    Halder N; Kelso JK; Milne GJ
    BMC Public Health; 2010 Mar; 10():168. PubMed ID: 20346187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009.
    Kelso JK; Halder N; Milne GJ
    PLoS One; 2010 Nov; 5(11):e13797. PubMed ID: 21072188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response.
    McVernon J; McCaw JM; Nolan TM
    Aust N Z J Public Health; 2010 Apr; 34(2):113-9. PubMed ID: 23331352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California.
    Hunter JC; Rodríguez DC; Aragón TJ
    BMC Public Health; 2012 Jan; 12():82. PubMed ID: 22276659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico.
    Gutiérrez-Mendoza LM; Schwartz B; Méndez de Lira Jde J; Wirtz VJ
    Bull World Health Organ; 2012 Oct; 90(10):782-7. PubMed ID: 23109746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?
    Greer AL
    BMC Public Health; 2013 Jul; 13():669. PubMed ID: 23866760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivirals in the 2009 pandemic--lessons and implications for future strategies.
    Berera D; Zambon M
    Influenza Other Respir Viruses; 2013 Nov; 7 Suppl 3(Suppl 3):72-9. PubMed ID: 24215385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty.
    Greer AL; Schanzer D
    PLoS One; 2013; 8(6):e67253. PubMed ID: 23805303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpile.
    McCaw JM; Wood JG; McBryde ES; Nolan TM; Wu JT; Lipsitch M; McVernon J
    Med J Aust; 2009 Aug; 191(3):136-7. PubMed ID: 19645639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigation strategies for pandemic influenza A: balancing conflicting policy objectives.
    Hollingsworth TD; Klinkenberg D; Heesterbeek H; Anderson RM
    PLoS Comput Biol; 2011 Feb; 7(2):e1001076. PubMed ID: 21347316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017.
    Qualls N; Levitt A; Kanade N; Wright-Jegede N; Dopson S; Biggerstaff M; Reed C; Uzicanin A;
    MMWR Recomm Rep; 2017 Apr; 66(1):1-34. PubMed ID: 28426646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia.
    Bolton KJ; McCaw JM; Moss R; Morris RS; Wang S; Burma A; Darma B; Narangerel D; Nymadawa P; McVernon J
    Bull World Health Organ; 2012 Apr; 90(4):264-71. PubMed ID: 22511822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can antiviral drugs contain pandemic influenza transmission?
    Becker NG; Wang D
    PLoS One; 2011 Mar; 6(3):e17764. PubMed ID: 21464934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of optimal antiviral stockpile for a novel influenza pandemic.
    Kim S; Bin Seo Y; Lee J; Kim YS; Jung E
    J Infect Public Health; 2022 Jul; 15(7):720-725. PubMed ID: 35667304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Logistics of control for an influenza pandemic.
    Arinaminpathy N; McLean AR
    Epidemics; 2009 Jun; 1(2):83-8. PubMed ID: 21352754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2009 influenza pandemic: promising lessons for antiviral therapy for future outbreaks.
    Bavagnoli L; Maga G
    Curr Med Chem; 2011; 18(35):5466-75. PubMed ID: 22087838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated preparedness and response framework for influenza pandemics.
    Holloway R; Rasmussen SA; Zaza S; Cox NJ; Jernigan DB
    MMWR Recomm Rep; 2014 Sep; 63(RR-06):1-18. PubMed ID: 25254666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.